Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

The chapter explains that there are many genetic skin disorders affecting skin cell formation, including both common and rare types.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Higher cholesterol levels increase aggressive prostate cancer risk.

Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Terbinafine can cause hair loss.

Cyclosporin doesn't stop hair loss.

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Thyroid hormones affect skin texture, hair and nail growth, and can cause skin diseases related to thyroid problems.

Understanding skin structure and development helps diagnose and treat skin disorders.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Testosterone therapy increases bone density in older men with low testosterone levels.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.